Use of a statistical strategy to evaluate sources of variability in viral safety experiments for a recombinant biopharmaceutical.
McAllister
P R
PR
SmithKline Beecham Pharmaceuticals, Department of Statistical Sciences, King of Prussia, PA, USA.
Shadle
P J
PJ
Smith
T M
TM
Scott
R G
RG
Lubiniecki
A S
AS
D000818:Animals; D001688:Biological Products / Q000592:standards*; D016466:CHO Cells; D006224:Cricetinae; D004340:Drug Contamination / Q000706:statistics & numerical data*; D009052:Leukemia Virus, Murine / Q000302:isolation & purification*; D011994:Recombinant Proteins / Q000302:isolation & purification*; D012044:Regression Analysis; D015203:Reproducibility of Results
D001688:Biological Products; D011994:Recombinant Proteins